Shire plc (LSE: SHP, NASDAQ: SHPG) announces that its Non-Executive Director, William Burns, was appointed as a Non-Executive Director of Mesoblast Limited on March 6, 2014.
This disclosure is made pursuant to paragraph 9.6.14 of the UK Listing Rules.
Deputy Company Secretary
For further information please contact:
+1 781 482 0733
+1 781 482 0999
+44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
Click here for the PDF version of this press release.